6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: Akari Therapeutics Plc
Filed: February 3, 2014
Period of Report: February 3, 2014
Accession Number: 0001144204-14-005617

View Document ↗ View on SEC.gov ↗